Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2008

01-11-2008 | Article

Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age

Authors: D. Marchaim, R. Zaidenstein, T. Lazarovitch, Y. Karpuch, T. Ziv, M. Weinberger

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2008

Login to get access

Abstract

Increased resistance among isolates causing bacteremia constitutes a major challenge to medical practitioners and institutions. Variability between institutes is substantial, and requires the individual analysis of local trends. An eight-year (1997–2004) surveillance study of episodes of bacteremia was conducted in an 850-bed university hospital in central Israel. Trends of incidence, resistance, age, and mortality were analyzed. We studied 6,096 patient-unique episodes of bacteremia, of which, 2,722 (45.3%) were nosocomial and 523 (9.2%) involved children less than 18 years of age. The overall incidence of bacteremia episodes has increased over the study years by 39% and the patient mean age by 7.5 years. Gram-negative organisms accounted for 72% of hospital-acquired cases and 69% of community-acquired cases. There was a substantial increase in the incidence of nosocomial episodes, predominantly due to Gram-negative isolates, mainly Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli. Increased resistance to broad-spectrum antibiotics was noted among Gram-negative organisms, including quinolones (in K. pneumoniae), imipenem (A. baumannii and P. aeruginosa), piperacillin-tazobactam (K. pneumoniae), and amikacin (A. baumannii and P. aeruginosa). Increased resistance to oxacillin among coagulase-negative staphylococci was also noted. The all-cause mortality rates showed a significant rise. The patient age, intensive care unit (ICU) stay, and hospital acquisition were independently associated with mortality. We describe an increase in the incidence and resistance of Gram-negative organisms causing bacteremia and concomitant ageing of the patients with bacteremia. Similar patterns have been reported from other localities, and are of real concern.
Literature
1.
go back to reference Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM (2004) New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 4:751–760PubMedCrossRef Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM (2004) New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 4:751–760PubMedCrossRef
2.
go back to reference Bishara, J, Leibovici L, Ashkenazi S, Samra Z, Pitlik S (2000) Seven-year study of bacteraemic pneumonia in a single institution. Eur J Clin Microbiol Infect Dis 19:926–931PubMedCrossRef Bishara, J, Leibovici L, Ashkenazi S, Samra Z, Pitlik S (2000) Seven-year study of bacteraemic pneumonia in a single institution. Eur J Clin Microbiol Infect Dis 19:926–931PubMedCrossRef
3.
go back to reference Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317PubMedCrossRef Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317PubMedCrossRef
4.
go back to reference Raveh D, Rudensky B, Schlesinger Y, Benenson S, Yinnon AM (2003) Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990–2000). J Hosp Infect 55:196–203PubMedCrossRef Raveh D, Rudensky B, Schlesinger Y, Benenson S, Yinnon AM (2003) Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990–2000). J Hosp Infect 55:196–203PubMedCrossRef
5.
go back to reference Elhanan G, Raz R, Pitlik SD, Sharir R, Konisberger H, Samra Z, Kennes Y, Drucker M, Leibovici L (1995) Bacteraemia in a community and a university hospital. J Antimicrob Chemother 36:681–695PubMedCrossRef Elhanan G, Raz R, Pitlik SD, Sharir R, Konisberger H, Samra Z, Kennes Y, Drucker M, Leibovici L (1995) Bacteraemia in a community and a university hospital. J Antimicrob Chemother 36:681–695PubMedCrossRef
6.
go back to reference Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW (2005) Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760–766PubMedCrossRef Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW (2005) Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760–766PubMedCrossRef
7.
go back to reference Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA (2003) Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123:1615–1624PubMedCrossRef Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA (2003) Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123:1615–1624PubMedCrossRef
8.
go back to reference Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27:887–892PubMedCrossRef Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27:887–892PubMedCrossRef
9.
go back to reference Borer A, Gilad J, Menashe G, Peled N, Riesenberg K, Schlaeffer F (2002) Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Med Sci Monit 8:CR44–CR47PubMed Borer A, Gilad J, Menashe G, Peled N, Riesenberg K, Schlaeffer F (2002) Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Med Sci Monit 8:CR44–CR47PubMed
10.
go back to reference Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386PubMedCrossRef Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386PubMedCrossRef
11.
go back to reference Fraser A, Paul M, Almanasreh N, Tacconelli E, Frank U, Cauda R, Borok S, Cohen M, Andreassen S, Nielsen AD, Leibovici L; TREAT Study Group (2006) Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 119:970–976PubMedCrossRef Fraser A, Paul M, Almanasreh N, Tacconelli E, Frank U, Cauda R, Borok S, Cohen M, Andreassen S, Nielsen AD, Leibovici L; TREAT Study Group (2006) Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 119:970–976PubMedCrossRef
12.
go back to reference Clinical and Laboratory Standards Institute (CLSI) (2006) Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Approved standard M100-S16. CLSI, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2006) Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Approved standard M100-S16. CLSI, Wayne, PA
13.
go back to reference National Nosocomial Infections Surveillance System (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485CrossRef National Nosocomial Infections Surveillance System (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485CrossRef
14.
go back to reference Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samel C, Barbagallo S, Arentzen J, Lautenbach E (2006) Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med 166:1289–1294PubMedCrossRef Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samel C, Barbagallo S, Arentzen J, Lautenbach E (2006) Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med 166:1289–1294PubMedCrossRef
15.
go back to reference Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, Ko WC (2006) Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996–2003. J Microbiol Immunol Infect 39:135–143PubMed Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, Ko WC (2006) Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996–2003. J Microbiol Immunol Infect 39:135–143PubMed
16.
go back to reference Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, Fishbain J, Craft D, Riddell S, Lindler L, Mancuso J, Milstrey E, Bautista CT, Patel J, Ewell A, Hamilton T, Gaddy C, Tenney M, Christopher G, Petersen K, Endy T, Petruccelli B (2007) An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 44:1577–1584PubMedCrossRef Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, Fishbain J, Craft D, Riddell S, Lindler L, Mancuso J, Milstrey E, Bautista CT, Patel J, Ewell A, Hamilton T, Gaddy C, Tenney M, Christopher G, Petersen K, Endy T, Petruccelli B (2007) An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 44:1577–1584PubMedCrossRef
17.
go back to reference Frank M, Gur E, Givon-Lavi N, Peled N, Dagan R, Leibovitz E (2005) Nosocomial bloodstream infections in children and adolescents in southern Israel: a 10-year prospective study (1992–2001). Scand J Infect Dis 37:177–183PubMedCrossRef Frank M, Gur E, Givon-Lavi N, Peled N, Dagan R, Leibovitz E (2005) Nosocomial bloodstream infections in children and adolescents in southern Israel: a 10-year prospective study (1992–2001). Scand J Infect Dis 37:177–183PubMedCrossRef
18.
go back to reference Jerassy Z, Yinnon AM, Mazouz-Cohen S, Benenson S, Schlesinger Y, Rudensky B, Raveh D (2006) Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002. J Hosp Infect 62:230–236PubMedCrossRef Jerassy Z, Yinnon AM, Mazouz-Cohen S, Benenson S, Schlesinger Y, Rudensky B, Raveh D (2006) Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002. J Hosp Infect 62:230–236PubMedCrossRef
19.
go back to reference Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M (2007) The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988–2004. Isr Med Assoc J 9:424–429PubMed Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M (2007) The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988–2004. Isr Med Assoc J 9:424–429PubMed
20.
go back to reference Falagas ME, Kasiakou SK, Nikita D, Morfou P, Georgoulias G, Rafailidis PI (2006) Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital. BMC Infect Dis 6:99PubMedCrossRef Falagas ME, Kasiakou SK, Nikita D, Morfou P, Georgoulias G, Rafailidis PI (2006) Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital. BMC Infect Dis 6:99PubMedCrossRef
21.
go back to reference Ben-Ami, R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934PubMedCrossRef Ben-Ami, R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934PubMedCrossRef
22.
go back to reference Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y (2006) Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50:1257–1262PubMedCrossRef Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y (2006) Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50:1257–1262PubMedCrossRef
23.
go back to reference Paul M, Weinberger M, Siegman-Igra Y, Lazarovitch T, Ostfeld I, Boldur I, Samra Z, Shula H, Carmeli Y, Rubinovitch B, Pitlik S (2005) Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997–2002. J Hosp Infect 60:256–260PubMedCrossRef Paul M, Weinberger M, Siegman-Igra Y, Lazarovitch T, Ostfeld I, Boldur I, Samra Z, Shula H, Carmeli Y, Rubinovitch B, Pitlik S (2005) Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997–2002. J Hosp Infect 60:256–260PubMedCrossRef
24.
go back to reference Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y (2005) Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 11:22–29PubMed Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y (2005) Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 11:22–29PubMed
25.
go back to reference Grupper M, Sprecher H, Mashiach T, Finkelstein R (2007) Attributable mortality of nosocomial Acinetobacter bacteremia. Infect Control Hosp Epidemiol 28:293–298PubMedCrossRef Grupper M, Sprecher H, Mashiach T, Finkelstein R (2007) Attributable mortality of nosocomial Acinetobacter bacteremia. Infect Control Hosp Epidemiol 28:293–298PubMedCrossRef
26.
go back to reference Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, Porath A, Rimar D, Almog Y, Gilad J (2003) Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54:32–38PubMedCrossRef Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, Porath A, Rimar D, Almog Y, Gilad J (2003) Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54:32–38PubMedCrossRef
27.
go back to reference Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 50:59–69PubMedCrossRef Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 50:59–69PubMedCrossRef
28.
29.
go back to reference Lee CC, Chen SY, Chang IJ, Chen SC, Wu SC (2007) Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine (Baltimore) 86:138–144CrossRef Lee CC, Chen SY, Chang IJ, Chen SC, Wu SC (2007) Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine (Baltimore) 86:138–144CrossRef
30.
go back to reference Nakamura T, Takahashi O, Matsui K, Shimizu S, Setoyama M, Nakagawa M, Fukui T, Morimoto T (2006) Clinical prediction rules for bacteremia and in-hospital death based on clinical data at the time of blood withdrawal for culture: an evaluation of their development and use. J Eval Clin Pract 12:692–703PubMedCrossRef Nakamura T, Takahashi O, Matsui K, Shimizu S, Setoyama M, Nakagawa M, Fukui T, Morimoto T (2006) Clinical prediction rules for bacteremia and in-hospital death based on clinical data at the time of blood withdrawal for culture: an evaluation of their development and use. J Eval Clin Pract 12:692–703PubMedCrossRef
31.
go back to reference Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M (2006) The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect 64:282–287PubMedCrossRef Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M (2006) The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect 64:282–287PubMedCrossRef
32.
go back to reference Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166–174PubMedCrossRef Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166–174PubMedCrossRef
33.
go back to reference Carmeli Y, Eliopoulos G, Mozaffari E, Samore M (2002) Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162:2223–2228PubMedCrossRef Carmeli Y, Eliopoulos G, Mozaffari E, Samore M (2002) Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162:2223–2228PubMedCrossRef
34.
go back to reference Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH (2006) Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 34:2588–2595PubMedCrossRef Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH (2006) Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 34:2588–2595PubMedCrossRef
35.
go back to reference Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, Giladi M (2002) Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 34:1431–1439PubMedCrossRef Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, Giladi M (2002) Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 34:1431–1439PubMedCrossRef
Metadata
Title
Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age
Authors
D. Marchaim
R. Zaidenstein
T. Lazarovitch
Y. Karpuch
T. Ziv
M. Weinberger
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0545-z

Other articles of this Issue 11/2008

European Journal of Clinical Microbiology & Infectious Diseases 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.